The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host, which compositions comprise viable non-pathogenic or attenuated pathogenic Clostridia. The vibratory conveying apparatus comprising a conveying chute having a first conveying surface that is connected to a driving source by a leaf spring that is reciprocatingly vibrated by the driving source. If a link has been successfully established, the MIH client may start a MIH session. 2 to q43, human chromosome 2 p11.